E Samantas

Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.

P. Kosmidis, E Samantas, George Fountzilas et al. · PubMed · 1994 · 88 citations

Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma

George Fountzilas, Christos Tolis, Anna Kalogera‐Fountzila et al. · Strahlentherapie und Onkologie · 2005 · 28 citations · Full text

Radiation Therapy, Medicine, Cancer Management +9

Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.

P. Kosmidis, N. Mylonakis, George Fountzilas et al. · PubMed · 1997 · 21 citations

Prognostic Factors and Significance of the Revised 6th Edition of the AJCC Classification in Patients with Locally Advanced Nasopharyngeal Carcinoma

Anna Kalogera‐Fountzila, Dimitrios Karanikolas, Nikos Katodritis et al. · Strahlentherapie und Onkologie · 2006 · 20 citations · Full text

Prognostic Factors, Esophageal Cancer, Ajcc Classification +8

Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.

P. Kosmidis, N. Mylonakis, Nikolaos Pavlidis et al. · PubMed · 2000 · 19 citations